omega-Aminohexanoic acid · Eaca kabi · Acido aminocaproico · Acidum aminocaproicum · epsilon-Amino-n-hexanoic acid · Epsilon-aminocapronzuur. 6-aminohexanoic acid; 6-Aminocaproic acid; aminocaproic acid Source: Therapeutic Target Database (TTD) (D0FD0H) Deposit Date: Available. 6-Aminocaproic acid; 6-aminohexanoic acid; Acide aminocaproïque. Ácido aminocapróico. acidum aminocaproicum. Aminocaproic Acid; Aminocapronsäure .
|Published (Last):||6 February 2004|
|PDF File Size:||11.40 Mb|
|ePub File Size:||5.39 Mb|
|Price:||Free* [*Free Regsitration Required]|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Ingredient matches for Acido Aminocaproico Aminocaproic Acid Aminocaproic Acid is reported as an ingredient of Acido Aminocaproico in the following countries: Frantisek Mares, “Process for producing caprolactam from 6-aminocaproic acid.
Vatreptacog alfa Aminocaproic Acid may increase the thrombogenic activities of Vatreptacog alfa. Kallidinogenase Aminocaproic Acid may increase the thrombogenic activities of Kallidinogenase. June Learn how and when to remove this template message.
Available for Android and iOS devices. Archives of Internal Medicine. Tretinoin The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminocaproic Acid. Effect of a synthetic carboxy-terminal peptide of alpha 2 -antiplasmin on urokinase-induced fibrinolysis.
This article needs additional citations for verification.
Retrieved from ” https: Subscribe to free Drugs. The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminocaproic Acid.
Please help improve this article by adding citations to reliable sources. Beroctocog alfa Aminocaproic Acid may increase the thrombogenic activities of Beroctocog alfa.
A Tissue-type plasminogen activator. Nat Rev Drug Discov. A few cases of acute overdosage with intravenous mainocaproico have been reported. Aprotinin Aminocaproic Acid may increase the thrombogenic activities of Aprotinin.
Drug created on June 13, An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. The intravenous and oral LD 50 were 3. A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to 6-aminohexanoic acid and caprolactam. Aminocaproic acid is also an intermediate in the polymerization of Nylon-6, where it is formed by ring-opening hydrolysis of caprolactam.
Such enzymes include proteolytic enzymes like plasminthe enzyme responsible for fibrinolysis. IUPAC name 6-aminohexanoic acid. This means it is still under development and may contain inaccuracies. The mean lag time in absorption is 10 minutes.
Nonacog beta pegol Aminocaproic Acid may increase the thrombogenic activities of Nonacog beta pegol.
It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Recombinant kringle IV modules of human apolipoprotein a: Turoctocog alfa Aminocaproic Acid may increase the thrombogenic activities of Turoctocog alfa. Aminocaproic Acid Action Pathway. Aminocaproic acid binds reversibly to the kringle domain of plasminogen and blocks the binding of plasminogen to fibrin and its activation to plasmin.
Elevated plasma levels of lipoprotein a have been shown to increase the risk of vascular disease. Patent US, issued August, Hydrogen peroxide Aminocaproic Acid may increase the thrombogenic activities of Hydrogen peroxide. The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death.
Drug Interaction Alphaproteinase inhibitor Alphaproteinase inhibitor may increase the thrombogenic activities of Aminocaproic Acid. Etamsylate Carbazochrome Batroxobin thrombopoietin receptor agonist Romiplostim Avatrombopag Eltrombopag Lusutrombopag.
Human Co colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator. General Function Serine-type endopeptidase activity Specific Function Apo a is the main constituent of lipoprotein a Lp a. From Wikipedia, the free encyclopedia. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator. Renal excretion is the primary route of elimination, whether aminocaproic acid is administered orally or intravenously.
Acido Aminocaproico [DCIT,Spanish]
Texas Heart Institute Journal. Rockville, MD; Jul. Drugs, their aminocaproic and the nature and number of drug targets. Emicizumab Aminocaproic Acid may increase the thrombogenic activities of Emicizumab. Acido Aminocaproico Acido Aminocaproico may be available in the countries listed below.